The virologist and researcher at the CSIC’s National Center for Biotechnology Juan Garcia Arriaza is part of the study that demonstrates the effect of a vaccine that they have developed that protects against infection and brain damage caused by the SARS-Cov-2.
The research, carried out with mariano esteban and a team from the Institute of Biomedicine of Seville, is a pioneer and has been published in the journal Nature Neuroscience. Garcia Arriaza has discussed this important finding with snow blacksmith in Madrid Direct of Onda Madrid.
Juan Garcia Arriaza has commented that “in this study in mice we have shown that the virus infects different parts of the brain and neurons that it kills.”Sarscov2 also infects the brain and our vaccine prevents it”, and adds that “in mouse models our vaccine fully protects the brain.
“No vaccine is totally sterilizing at the lung level”
The virologist warns that “no vaccine is completely sterilizing at the lung level, and adds that” regulatory agencies look at everything in detail to authorize vaccines, we go hand in hand with the company Biofabri to test the vaccine in people. We have collaborated with a group from Seville who are experts in brains.”
And he concludes: “As a country it is important to have vaccines to be used. Greasing the biotechnological system is important for future pandemics”, and stresses that “in spain It was very difficult to carry out studies on macaques and we have managed to tear down that wall”.